Abstract
Involuntary abnormal movements have been reported after ischaemic and haemorrhagic stroke. Post stroke movement disorders can appear as acute or delayed sequel. At the moment, for many of these disorders the knowledge of pharmacological treatment is still inadequate. Dopaminergic and GABAergic systems may be mainly involved in poststroke movement disorders. This article provides a review on drugs commonly used in post-stroke movement disorders, given that some post-stroke movement disorders have shown a partial benefit with pharmacological approach.
Keywords: Post-stroke, movement disorders, hyperkinetic movements disorders, hypokinetic movements disorders, GABA, Dopamine, post-stroke recovery
Current Neuropharmacology
Title:Post-stroke Movement Disorders: Clinical Manifestations and Pharmacological Management
Volume: 10 Issue: 3
Author(s): Antonio Siniscalchi, Luca Gallelli, Angelo Labate, Giovanni Malferrari, Caterina Palleria and Giovambattista De Sarro
Affiliation:
Keywords: Post-stroke, movement disorders, hyperkinetic movements disorders, hypokinetic movements disorders, GABA, Dopamine, post-stroke recovery
Abstract: Involuntary abnormal movements have been reported after ischaemic and haemorrhagic stroke. Post stroke movement disorders can appear as acute or delayed sequel. At the moment, for many of these disorders the knowledge of pharmacological treatment is still inadequate. Dopaminergic and GABAergic systems may be mainly involved in poststroke movement disorders. This article provides a review on drugs commonly used in post-stroke movement disorders, given that some post-stroke movement disorders have shown a partial benefit with pharmacological approach.
Export Options
About this article
Cite this article as:
Siniscalchi Antonio, Gallelli Luca, Labate Angelo, Malferrari Giovanni, Palleria Caterina and De Sarro Giovambattista, Post-stroke Movement Disorders: Clinical Manifestations and Pharmacological Management, Current Neuropharmacology 2012; 10 (3) . https://dx.doi.org/10.2174/157015912803217341
DOI https://dx.doi.org/10.2174/157015912803217341 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pharmacogenomics and Personalized Medicine for the Developing World - Too Soon or Just-in-Time? A Personal View from the World Health Organization
Current Pharmacogenomics and Personalized Medicine Cerebellum, GABA and Ataxia
Current Psychopharmacology Meet Our Editorial Board Member
Current Alzheimer Research Training Children to Reduce Motion and Increase Success of MRI Scanning
Current Medical Imaging Purification and Properties of β-Alanine Synthase from Calf Liver
Protein & Peptide Letters Neuro-Inflammatory Mechanisms in Developmental Disorders Associated with Intellectual Disability and Autism Spectrum Disorder: A Neuro- Immune Perspective
CNS & Neurological Disorders - Drug Targets Recent Approaches for Studying the Role of Glia
CNS & Neurological Disorders - Drug Targets Cognitive Behavioral Therapy for Psychosis Prevention and Treatment in Youth
Current Psychiatry Reviews Transforming Growth Factor-β Signaling in Motor Neuron Diseases
Current Molecular Medicine Enriched Environments for Rodents and their Interaction with Nicotine Administration
Current Drug Abuse Reviews Opportunities to Discover Genes Regulating Depression and Antidepressant Response from Rodent Behavioral Genetics
Current Pharmaceutical Design Novel 11,12H-dihydronaphthalene[1,2-b]quinoline as Atypical Antipsychotic
Letters in Drug Design & Discovery Recents Patents for Isolating, Delivering and Tracking Adult Stem Cells in Regenerative Medicine
Recent Patents on Drug Delivery & Formulation Electroporation Advances in Large Animals
Current Gene Therapy Tomographic Imaging Methods and Gated Technique in Nuclear Cardiology: A Review on Current Status and Future Developments
Recent Patents on Medical Imaging Targeting the Eph System with Peptides and Peptide Conjugates
Current Drug Targets Hashimoto’s Encephalopathy Presenting as Recurrent Brief Psychotic Episodes in a 13-Year-Old Girl: A Case Report
Adolescent Psychiatry Towards Drug Discovery for Brain Tumours: Interaction of Kinins and Tumours at the Blood Brain Barrier Interface
Recent Patents on CNS Drug Discovery (Discontinued) Neuropsychiatric and Cognitive Symptoms in Spinocerebellar Ataxia: Relationship to Neuropathological Differences
Current Psychiatry Reviews Adverse HBOC-Endothelial Dysfunction Synergism: A Possible Contributor to Adverse Clinical Outcomes?
Current Drug Discovery Technologies